Does PIMAVANSERIN Cause Therapeutic product effect delayed? 71 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Therapeutic product effect delayed have been filed in association with PIMAVANSERIN (pimavanserin). This represents 0.2% of all adverse event reports for PIMAVANSERIN.
71
Reports of Therapeutic product effect delayed with PIMAVANSERIN
0.2%
of all PIMAVANSERIN reports
3
Deaths
6
Hospitalizations
How Dangerous Is Therapeutic product effect delayed From PIMAVANSERIN?
Of the 71 reports, 3 (4.2%) resulted in death, 6 (8.5%) required hospitalization.
Is Therapeutic product effect delayed Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PIMAVANSERIN. However, 71 reports have been filed with the FAERS database.
What Other Side Effects Does PIMAVANSERIN Cause?
Hallucination (10,839)
Death (9,352)
Drug ineffective (5,545)
Product dose omission issue (3,808)
Confusional state (3,779)
Fall (3,366)
Delusion (2,421)
Hallucination, visual (1,954)
Gait disturbance (1,923)
Parkinson's disease (1,918)
What Other Drugs Cause Therapeutic product effect delayed?
ADALIMUMAB (244)
TOFACITINIB (178)
CARBIDOPA\LEVODOPA (168)
SECUKINUMAB (162)
POLYETHYLENE GLYCOL 3350 (125)
RIMEGEPANT (120)
TASIMELTEON (93)
DUPILUMAB (90)
IBUPROFEN (88)
DICLOFENAC (85)
Which PIMAVANSERIN Alternatives Have Lower Therapeutic product effect delayed Risk?
PIMAVANSERIN vs PIMECROLIMUS
PIMAVANSERIN vs PIMOZIDE
PIMAVANSERIN vs PINAVERIUM
PIMAVANSERIN vs PINDOLOL
PIMAVANSERIN vs PIOGLITAZONE